Reza Mazhari

Reza Mazhari serves as Chief Business Officer at Delphia Therapeutics. Delphia Therapeutics operates in the research sector with approximately 27.0 employees. The company is headquartered in Boston, Massachusetts.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Route 53 Outlook Microsoft Office 365 Zendesk Squarespace ECommerce Mobile Friendly WordPress.org Google Tag Manager Google Font API Micro Hubspot

biotechnology research activation lethality cancer therapeutics precision medicine oncogene overactivation targeted therapy drug resistance bioinformatics tumor growth selective killing first-in-class cancer medicines oncogenic pathways drug discovery clinical development genomics synthetic lethality tumor genetics pathway hyperactivation anti-tumor activity innovative oncology patient benefit cancer biology therapeutic targets functional genomics crispr regulatory approval biotechnology treatment paradigm advanced oncology cancer drugs mutation resistance therapeutic innovation cancer challenges high-throughput screening molecular pathways prevalent cancer types discovery pipeline oncology drug developers personalized medicine biomedical research cancer patient populations druggable targets clinical research therapeutic strategies tumor microenvironment cancer resilience novel cancer treatments information technology & services

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Reza Mazhari in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Delphia Therapeutics.

Reza Mazhari's Position in the MessageCEO Database

• •Reza Mazhari is 1 of 1 verified executive contact we track at Delphia Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •45 verified contacts work at research companies in the 27.0 employee range (same size as Delphia Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Reza Mazhari directly?

Reza Mazhari's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at Delphia Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Reza Mazhari work for?

Reza Mazhari is Chief Business Officer at Delphia Therapeutics, a company in the research sector with 27.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Reza Mazhari?

As Chief Business Officer at Delphia Therapeutics, Reza Mazhari is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Reza Mazhari directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Reza Mazhari in?

Reza Mazhari works in the research industry as Chief Business Officer at Delphia Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Reza Mazhari's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Reza Mazhari's profile is kept up-to-date with the latest available information.

Last updated: July 23, 2026